Reduced Morg1 expression in ischemic human brain

Neuroscience Letters

Volumn 455, Issue 1, 2009, Pages 46-50

  Haase, Daniela ^a   Keiner, Silke ^a   Mawrin, Christian ^a,b   Wolf, Gunter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Brain; HIF 1; Ischemia; Morg1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATEDPROTEIN KINASE ORGANIZER 1; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BLOOD CELL; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN TISSUE; DOWN REGULATION; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 63449105562     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.048     Document Type: Article

References (16)

1. Aminova L.R., Siddiq A., and Ratan R.R. Antioxidants, HIF prolyl hydroxylase inhibitors or short interfering RNAs to BNIP3 or PUMA, can prevent prodeath effects of the tarnscriptional activator, HIF-1alpha, in a mouse hippocampal neuronal line. Antioxod. Redox Signal. 10 (2008) 1989-1998
2. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., and Sharp F.R. Induction of hypoxia-inducible fcator-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11 (1999) 4159-4170
3. Chu K., Jung K.H., Kim S.J., Lee S.T., Kim J., Park H.K., Song E.C., Kim S.U., Kim M., Lee S.K., and Roh J.K. Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1α stabilization in the host brain. Brain Res. 1207 (2008) 182-192
4. Hamrick S.E.G., McQuillen P.S., Jiang X., Mu D., Madan A., and Ferriero D.M. A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection. Neusci. Lett. 379 (2005) 96-100
5. Hopfer U., Hopfer H., Jablonski K., Stahl R.A.K., and Wolf G. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J. Biol. Chem. 281 (2006) 8645-8655
6. Kaynaer M.Y., Sanus G.Z., Hnimoglu H., Kacira T., Kemerdere R., Atukeren P., Gumustas K., Canbaz B., and Tanriverdi T. Expression of hypoxia factor-1α in tumors of patients with glioblastoma multiforme and transitional meningioma. J. Clin. Neuro. Sci. 15 (2008) 1036-1042
7. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., Farese R.V., Freeman R.S., Carter B.D., Kaelin W.G., and Sclisio S. Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 (2005) 155-167
8. Lipscomb E.A., Sarmiere P.D., and Freeman R.S. SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276 (2001) 5085-5091
9. Lomb D.J., Straub J.A., and Freeman R.S. Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation. J. Neurochem. 103 (2007) 1897-1906
10. Ran R., Xu H., Lu A., Bernaudin M., and Sharp F.R. Hypoxia preconditioning in the brain. Dev. Neurosci. 27 (2005) 87-92
11. Ratan R.R., Siddiq A., Smirnova N., Karpisha K., Haskew-Layton R., McConoughey S., Langley B., Estevez A., Huerta P.T., Volpe B., Roy S., Sen C.K., Gazaryan I., Cho S., Fink M., and LaManna J. Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J. Mol. Med. 85 (2007) 13331-21338
12. Siddiq A., Ayoub I.A., Chavez J.C., Aminova L., Shah S., LaManna J.C., Patton S.M., Connor J.R., Cherny R.A., Volitakis I., Bush A.I., Langsetmo I., Seeley T., Gunzler V., and Ratan R.R. Hypoxia-inducible factor prolyl 4-hydroxlase inhibition. J. Biol. Chem. 280 (2005) 41732-41743
13. Vomastek T., Schaeffer H.J., Tarcsafalvi A., Smolkin M.E., Bissonette E.A., and Weber M.J. Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 6981-6986
14. Yi J.H., Park S.W., Lapadia R., and Vemuganti R. Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem. Intern. 50 (2007) 1014-1027
15. Yin J.L., Shackel N.A., Zekry A., McGuinness P.H., Richards C., Putten K.V., McCaughan G.W., Eris J.M., and Bishop G.A. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with the fluorogenic probes or SYBR green I. Immunol. Cell Biol. 79 (2001) 213-221
16. waf1/cip1, and erythropoietin. J. Neurosci. 19 (1999) 9821-9830